Massive eye study reveals rare side effect of common injection
NCT ID NCT06769412
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 35 times
Summary
This study examined over 550,000 patients to find out how often retinal vasculitis (inflammation of blood vessels in the eye) occurs after treatment with aflibercept (Eylea®). Researchers reviewed medical records to confirm cases and identify types of vasculitis. The goal was to better understand the safety of this common eye injection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINAL VASCULITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Regeneron Research Site
Tarrytown, New York, 10591, United States
Conditions
Explore the condition pages connected to this study.